TrianglePUBLICATIONS · 22446022
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2012 Jul
- First author
- Bokemeyer C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bokemeyer C
- type
- Author
- name
- Van Cutsem E
- type
- Author
- name
- Rougier P
- type
- Author
- name
- Ciardiello F
- type
- Author
- name
- Heeger S
- type
- Author
- name
- Schlichting M
- type
- Author
- name
- Celik I
- type
- Author
- name
- Köhne CH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bokemeyer C
- type
- Author
- name
- Van Cutsem E
- type
- Author
- name
- Rougier P
- type
- Author
- name
- Ciardiello F
- type
- Author
- name
- Heeger S
- type
- Author
- name
- Schlichting M
- type
- Author
- name
- Celik I
- type
- Author
- name
- Köhne CH
- type
- Author
- bibliography ids
- nci-bib-9fdb1e854614f82aeb8ad59e
- book metadata
- content sha256
- 2d6b513c661c973cbe6b4f42ef3bfd215efe712da6915d195a3663635106f578
- document type
- citation
- dois
- 10.1016/j.ejca.2012.02.057
- electronic publication date
- display
- 2012 Mar 23
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22446022
- immutable id
- pubmed:22446022@2d6b513c661c973cbe6b4f42ef3bfd215efe712da6915d195a3663635106f578
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- 10
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 1466-75
- volume
- 48
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22446022
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 9a9021de248020956b1110d0b74e1274468b0c69214548f2b4f45f6b13d8c63d
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Jul
- precision
- month
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.
Preserved source evidence · Not medical advice